Transoral endoscopic thyroidectomy submental vestibular approach for early-stage papillary thyroid carcinoma: a systematic review and meta-analysis - Scorecard - MDSpire

Transoral endoscopic thyroidectomy submental vestibular approach for early-stage papillary thyroid carcinoma: a systematic review and meta-analysis

  • By

  • Mahmoud Diaa Hindawi

  • Ahmed Hamdy, G. Ali

  • Ruaa Mustafa Qafesha

  • Wesam Soliman

  • Haitham Salem

  • Eslam Bali

  • Amr Elrosasy

  • July 4, 2024

  • 0 min

Share

Clinical Scorecard: Submental Vestibular Approach for Transoral Endoscopic Thyroidectomy in Early-Stage Papillary Thyroid Carcinoma: A Systematic Review and Meta-Analysis

At a Glance

CategoryDetail
ConditionEarly-stage papillary thyroid carcinoma
Key MechanismsGenetic mutation activating mitogen-activated protein kinase leading to malignant transformation; surgical removal of thyroid tumors
Target PopulationPatients over 18 years old with early-stage papillary thyroid carcinoma
Care SettingSurgical care including minimally invasive and conventional thyroidectomy procedures

Key Highlights

  • Papillary thyroid carcinoma represents approximately 97% of differentiated thyroid neoplasms with high survival rates.
  • Conventional open thyroidectomy (COT) leaves a visible scar impacting quality of life; minimally invasive approaches aim to improve cosmetic outcomes.
  • The transoral endoscopic thyroidectomy submental vestibular approach (TOETSMVA) offers favorable surgical outcomes and complication profiles without increased costs or need for specialized instruments.

Guideline-Based Recommendations

Diagnosis

  • Diagnosis based on clinical presentation and confirmation of early-stage papillary thyroid carcinoma in adults.

Management

  • Surgical treatment is preferred for malignant thyroid tumors.
  • Minimally invasive approaches such as TOETSMVA and TOETVA are recommended alternatives to conventional open thyroidectomy for better cosmetic results.
  • TOETSMVA may be favored due to fewer complications and no additional cost or equipment requirements.

Monitoring & Follow-up

  • Monitor for surgical complications including recurrent laryngeal nerve injury, temporary hoarseness, lower lip and mandibular numbness.
  • Assess postoperative outcomes such as pain (VAS score), drainage volume, hospital stay length, and lymph node resection adequacy.

Risks

  • Potential for cutaneous paralysis of the midline chin with TOETVA.
  • Risks of nerve injury and sensory disturbances exist with all surgical approaches.

Patient & Prescribing Data

Adults with early-stage papillary thyroid carcinoma undergoing thyroidectomy

TOETSMVA provides comparable or improved surgical outcomes and complication rates compared to TOETVA and COT, with better cosmetic results and no increased cost or need for specialized instruments.

Clinical Best Practices

  • Select minimally invasive thyroidectomy approaches when feasible to improve cosmetic outcomes and patient satisfaction.
  • Use TOETSMVA to reduce surgical complications and avoid midline chin paralysis associated with TOETVA.
  • Apply standardized outcome measures including operation time, hospital stay, pain scores, and nerve injury incidence to evaluate surgical success.
  • Follow PRISMA and Cochrane guidelines for systematic evaluation of surgical techniques.
  • Employ risk-of-bias tools (ROB 2, NOS) and GRADE criteria to assess study quality and evidence strength.

References

Original Source(s)

Related Content